'To move from cost-based to value-based, Indian pharma needs radical reforms and a bold attitude' - in case you missed it, here is a summary of takeaways from our roundtable whitepaper on the topic 'Emerging Frameworks in Innovation'. To read the article, please visit: https://bit.ly/3Vi750F.
The roundtable was hosted by Dr. Reddy's and Dr. Reddy's Institute of Life Sciences (DRILS), and moderated by Citeline. The distinguished panel represented industry, Government, academia and science. The discussion noted the need for increased collaborative research, better funding mechanisms, accelerated reforms in the regulatory environment and the clinical trial infrastructure. It was a step towards building on the ongoing discussions in India on innovation in R&D in pharma and healthcare, through the multi-disciplinary lens of these eminent panelists. We look forward to continuing the momentum annually.
To read the full whitepaper, click here: https://bit.ly/3KxYmCu.
